From: Haemoglobin concentration and volume of intravenous fluids in septic shock in the ARISE trial
Treatments and outcomes | Cohort (N = 1275) |
---|---|
Treatments | |
Central venous cannula inserted – N (%) | 1053 (82.6%) |
Arterial cannula inserted – N (%) | 1082 (84.9%) |
Admitted to ICU – N (%) | 1092 (85.6%) |
Received surgery – N (%) | 117 (9.2%) |
Received mechanical ventilationa – N (%) | 480 (37.6%) |
Received an infusion of a vasoactive agentb – N (%) | 858 (67.3%) |
Duration of vasoactive agent infusion – hours (IQR) | 29 (12–57) |
Outcomes | |
Invasive ventilation | |
Number that received invasive ventilationc – N (%) | 352 (27.6%) |
Duration of invasive ventilation – hours (IQR) | 61 (22–163) |
Length of stay – days (IQR) | |
ICU | 2.6 (1.3–5.0) |
Hospital | 8.1 (4.9–15.3) |
Mortality – N (%) | |
ICU | 109 (8.5%) |
Hospital | 162 (12.7%) |
Day 28 | 163 (12.8%) |
Day 90 | 193 (15.1%) |